Hanjin Kal (KRX:180640)

Market Cap	7.26T
Revenue (ttm)	285.07B
Net Income (ttm)	455.15B
Shares Out	66.85M
EPS (ttm)	6,820.27
PE Ratio	16.01
Forward PE	n/a
Dividend	300.00 (0.27%)
Ex-Dividend Date	Dec 27, 2024

Volume	73,086
Average Volume	73,643
Open	108,100
Previous Close	110,000
Day's Range	108,000 - 111,600
52-Week Range	59,200 - 165,000
Beta	0.67
RSI	30.52
Earnings Date	Aug 13, 2025

About Blueprint Medicines

Hanjin Kal, together with its subsidiaries, engages in the provision of airline services in South Korea. The company offers aviation services, such as ground handling, flight operations management, and engine commissioning. It also provides services in investment, management consulting, licensing, real estate leasing business, tourism, and hotel operations. In addition, the company offers building management services, including building maintenance, parking lot operation and maintenance, and facility rental services. Hanjin Kal was incorporated...

• Industry: Lodging
• Sector: Consumer Discretionary
• Founded: 2013
• Employees: 25
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 180640

Financial Performance

In 2024, Hanjin Kal's revenue was 292.16 billion, an increase of 5.96% compared to the previous year's 275.73 billion. Earnings were 493.04 billion, an increase of 28.02%.